Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$178M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$95.3M |
| 3 |
Navient
NAVI
|
+$87.5M |
| 4 |
Broadcom
AVGO
|
+$84.4M |
| 5 |
ALTR
Altera Corp
ALTR
|
+$80.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
CELG
Celgene Corp
CELG
|
+$299M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$243M |
| 4 |
EOG Resources
EOG
|
+$220M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14% |
| 2 | Technology | 13.13% |
| 3 | Healthcare | 12.48% |
| 4 | Industrials | 11.07% |
| 5 | Energy | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Genesis Energy
GEL
$1.89B
| $6.1M | ﹤0.01% |
108,916
+44,709
| +70% | +$2.47M |
|
|
SPPI
2377
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $6.1M | ﹤0.01% |
750,226
-102,419
| -12% | -$777K |
|
2378
Ambarella
AMBA
$3.64B
| $6.09M | ﹤0.01% |
195,238
-9,488
| -5% | -$251K |
|
|
ENOC
2379
DELISTED
EnerNOC, Inc.
ENOC
| $6.07M | ﹤0.01% |
320,204
-18,842
| -6% | -$380K |
|
2380
Tronox
TROX
$1.02B
| $6.03M | ﹤0.01% |
224,318
+68,054
| +44% | +$1.74M |
|
|
DCM
2381
DELISTED
NTT DOCOMO, Inc.
DCM
| $6.02M | ﹤0.01% |
352,107
+28,575
| +9% | +$465K |
|
|
SGNT
2382
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $6.01M | ﹤0.01% |
232,427
-22,110
| -9% | -$491K |
|
2383
Forrester Research
FORR
$225M
| $6.01M | ﹤0.01% |
158,635
-29,328
| -16% | -$1.07M |
|
2384
Barings BDC
BBDC
$975M
| $5.99M | ﹤0.01% |
211,010
-108,777
| -34% | -$2.84M |
|
|
SC
2385
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $5.99M | ﹤0.01% |
307,886
+144,171
| +88% | +$3.08M |
|
|
GG
2386
DELISTED
Goldcorp Inc
GG
| $5.98M | ﹤0.01% |
214,237
+19,246
| +10% | +$478K |
|
2387
Vanguard Real Estate ETF
VNQ
$38.3B
| $5.96M | ﹤0.01% |
79,644
+35,391
| +80% | +$2.6M |
|
|
CQB
2388
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $5.96M | ﹤0.01% |
549,351
-70,607
| -11% | -$786K |
|
|
BNNY
2389
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
| $5.95M | ﹤0.01% |
176,022
-13,704
| -7% | -$460K |
|
2390
Angi Inc
ANGI
$182M
| $5.94M | ﹤0.01% |
49,734
-10,894
| -18% | -$1.24M |
|
|
GNMK
2391
DELISTED
GenMark Diagnostics, Inc
GNMK
| $5.93M | ﹤0.01% |
438,630
-28,939
| -6% | -$302K |
|
|
ANAC
2392
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $5.93M | ﹤0.01% |
334,545
-12,037
| -3% | -$194K |
|
2393
OraSure Technologies
OSUR
$268M
| $5.93M | ﹤0.01% |
688,802
-100,971
| -13% | -$708K |
|
|
SAAS
2394
DELISTED
inContact, Inc.
SAAS
| $5.92M | ﹤0.01% |
644,360
-102,834
| -14% | -$872K |
|
|
CLMS
2395
DELISTED
Calamos Asset Management, Inc.
CLMS
| $5.92M | ﹤0.01% |
441,741
-33,838
| -7% | -$432K |
|
2396
iShare MSCI Eurozone ETF
EZU
$9.91B
| $5.9M | ﹤0.01% |
139,436
+111,256
| +395% | +$4.77M |
|
|
AXAS
2397
DELISTED
Abraxas Petroleum Corp
AXAS
| $5.89M | ﹤0.01% |
47,036
-7,071
| -13% | -$721K |
|
2398
Central Pacific Financial
CPF
$996M
| $5.89M | ﹤0.01% |
296,551
-57,095
| -16% | -$1.1M |
|
2399
1st Source
SRCE
$2.12B
| $5.88M | ﹤0.01% |
211,384
-27,969
| -12% | -$783K |
|
|
AMRI
2400
DELISTED
Albany Molecular Research Inc
AMRI
| $5.86M | ﹤0.01% |
291,335
-25,884
| -8% | -$438K |
|
Similar funds
Northern Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Northern Trust held 4,323 positions worth $321B, up 0.95% from $318B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust withdrew a net $9.99B in Q2 2014, closing 74 positions and reducing 2,692 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $162M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Northern Trust opened a new position in Navient worth $93.7M.
- Northern Trust's largest Q2 2014 buy was Navient: 5,289,746 shares worth $93.7M.
- Northern Trust added most to Alphabet (Google) Class C in Q2 2014, an estimated $178M increase.
- Northern Trust's biggest Q2 2014 reduction was Apple, cutting an estimated $315M.
- Northern Trust fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $162M.
- Northern Trust's ten largest holdings make up 14% of its $321B portfolio in Q2 2014.
- Northern Trust opened 151 new positions and closed 74 in Q2 2014.
- Northern Trust's portfolio value rose 0.95% quarter-over-quarter to $321B.
Based on Northern Trust's 13F filing for Q2 2014, filed 14 Aug 2014.